The Importance of Tissue Quality for Molecular Techniques

Tissue Sample

Title: The Importance of Tissue Quality for Molecular Techniques

Date: Thursday, September 5

Time: 1:00 p.m. ET

Presenters: Jennifer Freeland, MS, HTL(ASCP)cm

Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.

Defining High-Quality Samples

In the age of molecular pathology, tissue specimen quality has been redefined.

Poor-quality tissue can lead to invalid results from next-generation sequencing and other molecular assays, which can negatively impact patient care. Although we’ve learned that certain pre-analytical factors influence the outcome of immunohistochemical assays, we’re still learning which specific factors impact molecular results.

Histology labs currently have procedures to help ensure sample quality, and high-quality H&E and IHC slides can typically be produced using routine surgical specimens. But the definition of specimen quality is changing with the advent of specific biomarker testing.

In this P.A.C.E.-accredited Fisher Healthcare webinar, Jennifer Freeland will discuss specimen quality criteria in the context of molecular methods, technical problems encountered during specimen preparation, and how these issues can be mitigated. She will review comparative studies as well as tissue quality assessments.

Learning Objectives

This webinar will help you:

  • Explain the tissue quality requirements for optimal molecular pathology test results
  • Differentiate the changes in sample preparation steps
  • Employ new quality control measures in your lab

Watch on Demand     

Download Slides (PDF, 2.47MB)

This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E. Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.


Joel E. Mortensen, PhD, FAAM, HCLD

Jennifer Freeland, MS, HTL(ASCP)cm

Freeland is a board of registry-certified histotechnologist with the American Society of Clinical Pathology. She has over 20 years of experience in routine histology, immunohistochemistry, and molecular and cellular biology.

Freeland earned her bachelor’s degree in biomedical science from Western Michigan University and her Master of Science in biotechnology from Johns Hopkins University. She has worked in clinical histology and research labs, research and development, quality, and technical consulting, and now serves as a global market development manager for Epredia.